Gaush Meditech

Gaush Meditech EBIT per Share

The EBIT per Share of Gaush Meditech (2407.HK) as of Nov 2, 2026 is 0.84 CNY. In the previous year, EBIT per Share was 1.14 CNY — a change of -26.16% (lower).

EBIT per Share

0.84CNY

YoY

-26.16%

Last updated:

EBIT per Share of Gaush Meditech is 2025 0.84 CNY. EBIT per Share of Gaush Meditech was 2024 1.14 CNY. It decreases by -26.16% lower compared to the previous year.

The Gaush Meditech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
1.09 CNY
Jan 1, 2021
1.54 CNY
Jan 1, 2022
2.11 CNY
Jan 1, 2023
1.61 CNY
Jan 1, 2024
1.14 CNY
Jan 1, 2025
0.84 CNY
Jan 1, 2026 (e)
1.99 CNY
Jan 1, 2027 (e)
2.32 CNY
The Gaush Meditech EBIT per Share history
YEAREBIT per ShareYoY
est2.32CNY+16.51%
est1.99CNY+135.83%
0.84CNY-26.16%
1.14CNY-29.21%
1.61CNY-23.58%
2.11CNY+37.24%
1.54CNY+41.17%
1.09CNY+2.48%
1.06CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Gaush Meditech Stock analysis

What does Gaush Meditech do? Gaush Meditech Ltd. generates revenue through four business segments. The Proprietary Products segment develops and sells surgical equipment, intraocular lenses, and diagnostic and treatment devices for ophthalmic diseases, along with related software and consumables. The Distribution segment distributes branded ophthalmic medical devices and consumables. The Technical Services segment offers after-sales services including warranty, maintenance, and consumables support. The Others segment handles equipment leasing and intellectual property agency services. Products are used in treating conditions like cataracts, glaucoma, and pediatric ophthalmology across various medical specialties. The company's primary customers include hospitals, clinics, and medical institutions specializing in ophthalmology. These institutions purchase proprietary devices, branded consumables, and technical support services. The firm's focus on ophthalmic subspecialties ensures consistent demand for its products and services in the treatment of eye diseases. Revenue streams are diversified across product development, distribution, and post-sale services. The proprietary segment drives innovation with surgical equipment and lenses, while distribution and technical services provide steady income from established medical partners. Equipment leasing and IP services in the Others segment contribute to additional revenue without requiring direct product sales. Gaush Meditech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gaush Meditech stock

EBIT per Share of Gaush Meditech is 0.84 CNY in 2025.

EBIT per Share of Gaush Meditech changed from 1.14 CNY to 0.84 CNY, representing a -26.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Gaush Meditech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Gaush Meditech

All Key Metrics — Gaush Meditech